Tags Reports - Allied Market Research

sale

Pediatric Home Healthcare Market

P

2023

Pediatric Home Healthcare Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global pediatric home healthcare market was valued at $37.2 billion in 2022 and is estimated to reach $71.2 billion by 2032, growing at a CAGR of 6.7% from 2023 to 2032.

Report Code : A107563 | Pages : 209 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Gastric Cancer Diagnostic Market

P

2023

Gastric Cancer Diagnostic Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global gastric cancer diagnostic market was valued at $2.3 billion in 2022, and is projected to reach $3.8 billion by 2032, growing at a CAGR of 5.3% from 2023 to 2032.

Report Code : A210376 | Pages : 260 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Neuroblastoma Drugs Market

P

2024

Neuroblastoma Drugs Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global neuroblastoma drugs market was valued at $0.7 billion in 2022, and is projected to reach $1.3 billion by 2032, growing at a CAGR of 6.2% from 2023 to 2032.

Report Code : A172697 | Pages : 256 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Lymphoma Therapeutics Market

P

2023

Lymphoma Therapeutics Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The lymphoma therapeutics market was valued at $15,691.45 million in 2022 and is projected to reach $35,207.45 million by 2032, registering a CAGR of 8.4% from 2023 to 2032.

Report Code : A01129 | Pages : 481 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Metastatic Cancer Drugs Market

P

2023

Metastatic Cancer Drugs Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global metastatic cancer drugs market was valued at $67.7 billion in 2022, and is projected to reach $136.9 billion by 2032, growing at a CAGR of 7.3% from 2023 to 2032.

Report Code : A109351 | Pages : 313 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Cancer Insurance Market

P

2024

Cancer Insurance Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global cancer insurance market was valued at $61.7 billion in 2022, and is projected to reach $159.9 billion by 2032, growing at a CAGR of 10.2% from 2023 to 2032.

Report Code : * A264275 | Pages : 400 | Category : BFSI

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Vacuum-assisted Biopsy Devices Market

P

2024

Vacuum-assisted Biopsy Devices Market: Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global vacuum-assisted biopsy devices market was valued at $0.9 billion in 2023, and is projected to reach $2.7 Billion by 2033, growing at a CAGR of 11.7% from 2024 to 2033

Report Code : A324535 | Pages : 280 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Uterine Cancer Therapeutics and Diagnostics Market

P

2024

Uterine Cancer Therapeutics and Diagnostics Market: Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global uterine cancer therapeutics and diagnostics market was valued at $2.4 billion in 2023, and is projected to reach $5.5 Billion by 2033, growing at a CAGR of 8.6% from 2024 to 2033

Report Code : A324056 | Pages : 280 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Artificial Intelligence In Cancer Diagnostics Market

P

2024

Artificial Intelligence In Cancer Diagnostics Market: Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global artificial intelligence in cancer diagnostics market was valued at $0.2 billion in 2023, and is projected to reach $1.7 Billion by 2033, growing at a CAGR of 23.6% from 2024 to 2033

Report Code : A323966 | Pages : 280 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Artificial Urinary Sphincter Implantation Device Market by Type

P

2024

Artificial Urinary Sphincter Implantation Device Market by Type : Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global artificial urinary sphincter implantation device market was valued at $0.5 billion in 2023, and is projected to reach $1.1 billion by 2033, growing at a CAGR of 7.2% from 2024 to 2033.

Report Code : A324368 | Pages : 280 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Breast Cancer Screening Market by Test Type

P

2024

Breast Cancer Screening Market by Test Type : Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global breast cancer screening market was valued at $2.9 billion in 2023, and is projected to reach $6.7 billion by 2033, growing at a CAGR of 8.7% from 2024 to 2033.

Report Code : A324383 | Pages : 280 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Colorectal Cancer Screening Market

P

2024

Colorectal Cancer Screening Market: Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global colorectal cancer screening market was valued at $17.1 billion in 2023, and is projected to reach $25.6 billion by 2033, growing at a CAGR of 4.1% from 2024 to 2033.

Report Code : A131436 | Pages : 280 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Cytotoxic Drug Market by Drug Type

P

2024

Cytotoxic Drug Market by Drug Type : Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global cytotoxic drug market was valued at $15.8 billion in 2023, and is projected to reach $19.5 billion by 2033, growing at a CAGR of 2.1% from 2024 to 2033.

Report Code : A324399 | Pages : 245 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Breast Lesion Localization Methods Market by Localization Methods

P

2024

Breast Lesion Localization Methods Market by Localization Methods : Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global breast lesion localization methods market was valued at $1.2 billion in 2023, and is projected to reach $3.6 billion by 2033, growing at a CAGR of 11.7% from 2024 to 2033.

Report Code : A324384 | Pages : 280 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Flow Cytometry In Oncology And Immunology Market

P

2024

Flow Cytometry In Oncology And Immunology Market: Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global flow cytometry in oncology and immunology market was valued at $2.3 billion in 2023, and is projected to reach $5.9 billion by 2033, growing at a CAGR of 9.9% from 2024 to 2033.

Report Code : A324004 | Pages : 216 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

U.S. Radiopharmaceuticals Market

P

2024

U.S. Radiopharmaceuticals Market: Opportunity Analysis and Industry Forecast, 2024 - 2033

The U.S. radiopharmaceuticals market was valued at $3.0 billion in 2023, and is projected to reach $7.9 billion by 2033, growing at a CAGR of 10.2% from 2024 to 2033.

Report Code : A92815 | Pages : 90 | Category : Life Sciences

Price:

~~$2,177~~ $1,524 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Australia Radiopharmaceuticals Market

P

2024

Australia Radiopharmaceuticals Market: Opportunity Analysis and Industry Forecast, 2024 - 2033

The Australia radiopharmaceuticals market was valued at $130.9 million in 2023, and is projected to reach $392.2 million by 2033, growing at a CAGR of 11.6% from 2024 to 2033.

Report Code : A92827 | Pages : 90 | Category : Life Sciences

Price:

~~$1,859~~ $1,301 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Asia-Pacific Radiopharmaceuticals Market

P

2024

Asia-Pacific Radiopharmaceuticals Market: Opportunity Analysis and Industry Forecast, 2024 - 2033

The Asia-Pacific radiopharmaceuticals market was valued at $1.9 billion in 2023, and is projected to reach $5.5 billion by 2033, growing at a CAGR of 11.4% from 2024 to 2033.

Report Code : A92824 | Pages : 110 | Category : Life Sciences

Price:

~~$1,859~~ $1,301 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

North America Radiopharmaceuticals Market

P

2024

North America Radiopharmaceuticals Market: Opportunity Analysis and Industry Forecast, 2024 - 2033

The North America radiopharmaceuticals market was valued at $3.2 billion in 2023, and is projected to reach $8.4 billion by 2033, growing at a CAGR of 10.2% from 2024 to 2033.

Report Code : A92814 | Pages : 110 | Category : Life Sciences

Price:

~~$2,443~~ $1,710 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

Results for Tags: cancer

Filter by Region

Filter by Discounts

Filter by Category

The global pediatric home healthcare market was valued at $37.2 billion in 2022 and is estimated to reach $71.2 billion by 2032, growing at a CAGR of 6.7% from 2023 to 2032.

The global gastric cancer diagnostic market was valued at $2.3 billion in 2022, and is projected to reach $3.8 billion by 2032, growing at a CAGR of 5.3% from 2023 to 2032.

The global neuroblastoma drugs market was valued at $0.7 billion in 2022, and is projected to reach $1.3 billion by 2032, growing at a CAGR of 6.2% from 2023 to 2032.

The lymphoma therapeutics market was valued at $15,691.45 million in 2022 and is projected to reach $35,207.45 million by 2032, registering a CAGR of 8.4% from 2023 to 2032.

The global metastatic cancer drugs market was valued at $67.7 billion in 2022, and is projected to reach $136.9 billion by 2032, growing at a CAGR of 7.3% from 2023 to 2032.

The global cancer insurance market was valued at $61.7 billion in 2022, and is projected to reach $159.9 billion by 2032, growing at a CAGR of 10.2% from 2023 to 2032.

The global vacuum-assisted biopsy devices market was valued at $0.9 billion in 2023, and is projected to reach $2.7 Billion by 2033, growing at a CAGR of 11.7% from 2024 to 2033

The global uterine cancer therapeutics and diagnostics market was valued at $2.4 billion in 2023, and is projected to reach $5.5 Billion by 2033, growing at a CAGR of 8.6% from 2024 to 2033

The global artificial intelligence in cancer diagnostics market was valued at $0.2 billion in 2023, and is projected to reach $1.7 Billion by 2033, growing at a CAGR of 23.6% from 2024 to 2033

The global artificial urinary sphincter implantation device market was valued at $0.5 billion in 2023, and is projected to reach $1.1 billion by 2033, growing at a CAGR of 7.2% from 2024 to 2033.

The global breast cancer screening market was valued at $2.9 billion in 2023, and is projected to reach $6.7 billion by 2033, growing at a CAGR of 8.7% from 2024 to 2033.

The global colorectal cancer screening market was valued at $17.1 billion in 2023, and is projected to reach $25.6 billion by 2033, growing at a CAGR of 4.1% from 2024 to 2033.

The global cytotoxic drug market was valued at $15.8 billion in 2023, and is projected to reach $19.5 billion by 2033, growing at a CAGR of 2.1% from 2024 to 2033.

The global breast lesion localization methods market was valued at $1.2 billion in 2023, and is projected to reach $3.6 billion by 2033, growing at a CAGR of 11.7% from 2024 to 2033.

The global flow cytometry in oncology and immunology market was valued at $2.3 billion in 2023, and is projected to reach $5.9 billion by 2033, growing at a CAGR of 9.9% from 2024 to 2033.

The U.S. radiopharmaceuticals market was valued at $3.0 billion in 2023, and is projected to reach $7.9 billion by 2033, growing at a CAGR of 10.2% from 2024 to 2033.

The Australia radiopharmaceuticals market was valued at $130.9 million in 2023, and is projected to reach $392.2 million by 2033, growing at a CAGR of 11.6% from 2024 to 2033.

The Asia-Pacific radiopharmaceuticals market was valued at $1.9 billion in 2023, and is projected to reach $5.5 billion by 2033, growing at a CAGR of 11.4% from 2024 to 2033.

The North America radiopharmaceuticals market was valued at $3.2 billion in 2023, and is projected to reach $8.4 billion by 2033, growing at a CAGR of 10.2% from 2024 to 2033.